Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care – Medical technologies guidance (MTG65)
NICE recommends use of the Sedaconda anaesthetic conserving device S as a cost saving option for delivering inhaled sedation in an intensive care setting when the volatile anaesthetics isoflurane or sevoflurane are being considered.
Source:
National Institute for Health and Care Excellence
SPS commentary:
This device conserves inhaled anaesthetics within the delivery system and any waste gas is captured by a passive or active gas scavenging system.
The guidance recommends further research to identify any health conditions or groups of patients that would benefit more from inhaled sedation with Sedaconda ACD‑S than from standard care.